Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins.

LPS binding to its receptor(s) on macrophages induces the synthesis of inflammatory mediators involved in septic shock. While the signaling mechanism(s) remains to be fully defined, the human LPS-binding protein (LBP) is known to regulate responses to LPS by facilitating its binding to CD14 on human monocytes. The structurally related bactericidal permeability increasing protein (BPI) differs from LBP by inhibiting LPS-induced human monocyte activation. We have demonstrated that, unlike the human monocyte response to LPS, both LBP and BPI inhibited LPS-stimulated TNF-alpha production in mouse peritoneal macrophages. In contrast, LPS-dependent nitric oxide release was not affected by LBP. LPS induces the phosphorylation of a number of proteins in a dose and time-dependent manner, however, the pattern of LPS-induced phosphorylation was not reduced by either LBP or BPI under conditions that result in selective TNF-alpha inhibition. Further, activation of the transcription factor NF-kappaB in response to LPS was also not modified by either LBP or BPI. Finally, no differences were detected in TNF-alpha or inducible nitric oxide synthase mRNA accumulations induced by LPS in the presence or absence of either protein, whereas a slight decreased mRNA stability was observed in the group with LPS treatment. These results would suggest that many of the early signaling events contribute to LPS-induced macrophage signaling at a point preceding the divergence of pathways that differentially regulate TNF-alpha and NO production.

[1]  C. Amura,et al.  Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages. , 1997, Journal of immunology.

[2]  G. Chaudhri Differential regulation of biosynthesis of cell surface and secreted TNF‐α in LPS‐stimulated murine macrophages , 1997, Journal of leukocyte biology.

[3]  N. Van Rooijen,et al.  Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. , 1997, Journal of immunology.

[4]  T. Standiford,et al.  Balance of inflammatory cytokines related to severity and mortality of murine sepsis , 1996, Infection and immunity.

[5]  S. Vogel,et al.  IL-10 differentially regulates mRNA expression induced by lipopolysaccharide and interferons in murine peritoneal macrophages , 1996 .

[6]  D. Morrison,et al.  Selective effects of serum on bacterial LPS-induced IL-6 and nitric oxide production in murine peritoneal macrophages , 1996 .

[7]  T. Suzuki,et al.  Both basal and enhancer κB elements are required for full induction of the mouse inducible nitric oxide synthase gene , 1996 .

[8]  S. L. Orlicek,et al.  Differential effects of tyrosine kinase inhibitors on tumor necrosis factor and nitric oxide production by murine macrophages. , 1996, The Journal of infectious diseases.

[9]  D. Harrich,et al.  Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B , 1996, Infection and immunity.

[10]  D. Hume,et al.  Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.

[11]  K. Murphy,et al.  Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway , 1996, Infection and immunity.

[12]  A. DeFranco,et al.  Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Matsushima,et al.  Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell‐free system targeting NF‐κB and regulation of cytokine production/action through β2 integrin in vivo , 1996, Journal of leukocyte biology.

[14]  John C. Lee,et al.  Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms , 1996, Journal of leukocyte biology.

[15]  F. Chen,et al.  Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages. , 1995, Biochemical and biophysical research communications.

[16]  D. Dunn,et al.  Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. , 1995, Surgery.

[17]  S. Nedospasov,et al.  Lipopolysaccharide-induced expression of TNF-alpha gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. , 1995, Journal of immunology.

[18]  I. Udalova,et al.  Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. , 1995, Oncogene.

[19]  M. McMahon,et al.  Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events , 1995, The Journal of experimental medicine.

[20]  S. Yamamoto,et al.  Suppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression. , 1995, Journal of immunology.

[21]  S. Endres,et al.  Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. , 1995, Journal of immunology.

[22]  D. Golenbock,et al.  CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide , 1995, The Journal of experimental medicine.

[23]  S. Nasraway,et al.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. , 1995, JAMA.

[24]  J. Gegner,et al.  Lipopolysaccharide (LPS) Signal Transduction and Clearance , 1995, The Journal of Biological Chemistry.

[25]  T. Kirikae,et al.  CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages , 1995, Infection and immunity.

[26]  A. Ding,et al.  Macrophages derived from C3H/HeJ (Lpsd ) mice respond to bacterial lipopolysaccharide by activating NF‐χB , 1995, Journal of leukocyte biology.

[27]  C. Amura,et al.  Tumor necrosis factor α plus interleukin 1β treatment protects granulocytopenic mice from Pseudomonas aeruginosa lung infection: Role of an unusual inflammatory response , 1995 .

[28]  R. Thieringer,et al.  CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. , 1994, The Journal of biological chemistry.

[29]  J. Haas,et al.  Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. , 1994, The Journal of biological chemistry.

[30]  Y. Uehara,et al.  Lipopolysaccharide‐induced cytokine production in human monocytes: Role of tyrosine phosphorylation in transmembrane signal transduction , 1994, European journal of immunology.

[31]  M. Nakano,et al.  Mitogenicity of bacterial lipopolysaccharide on the T lymphocyte population bearing the γδT cell receptor , 1994 .

[32]  C. Natanson,et al.  Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction , 1994 .

[33]  A. Levitzki,et al.  Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. , 1994, Science.

[34]  S. Carroll,et al.  Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria , 1994, Infection and immunity.

[35]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.

[36]  W. Buurman,et al.  Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. , 1993, Journal of immunology.

[37]  L. Wahl,et al.  Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. , 1993, The Journal of biological chemistry.

[38]  C. June,et al.  Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. , 1993, Journal of immunology.

[39]  D. Golenbock,et al.  Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide , 1993, Infection and immunity.

[40]  T. Suzuki,et al.  Influence of 3' half-site sequence of NF-kappa B motifs on the binding of lipopolysaccharide-activatable macrophage NF-kappa B proteins. , 1993, The Journal of biological chemistry.

[41]  T. Kirikae,et al.  Endotoxin receptors on mammalian cells. , 1993, Immunobiology.

[42]  S. Snyder,et al.  Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. , 1993, The Journal of biological chemistry.

[43]  B. Finlay,et al.  Soluble CD14 participates in the response of cells to lipopolysaccharide , 1992, The Journal of experimental medicine.

[44]  K. Tracey,et al.  Tumor Necrosis Factor and Regulation of Metabolism in Infection: Role of Systemic versus Tissue Levels , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[45]  B. Beutler Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. , 1992, The American journal of the medical sciences.

[46]  C. Nathan,et al.  Gram‐negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  H. Wortis,et al.  Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. , 1991, International immunology.

[48]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[49]  A. Israël,et al.  The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product , 1990, Cell.

[50]  C. E. Ooi,et al.  Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. , 1989, The Journal of biological chemistry.

[51]  P. Sehgal,et al.  Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts , 1987, The Journal of experimental medicine.

[52]  J. Goldstein,et al.  Atherosclerosis: Scavenger cell receptor shared , 1985, Nature.

[53]  R. Ulevitch,et al.  Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. , 1995, Annual review of immunology.

[54]  C. Manthey,et al.  Dissection of LPS-induced signaling pathways in murine macrophages using LPS analogs, LPS mimetics, and agents unrelated to LPS. , 1995, Progress in clinical and biological research.

[55]  E. Coligan Current protocols in immunology , 1991 .

[56]  J. Goldstein,et al.  Scavenger cell receptor shared. , 1985, Nature.